Literature DB >> 21131379

Lack of scientific rationale for use of valproic acid for retinitis pigmentosa.

Michael A Sandberg, Bernard Rosner, Carol Weigel-DiFranco, Eliot L Berson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21131379     DOI： 10.1136/bjo.2010.198176

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

Review 1.  Learning to see again: biological constraints on cortical plasticity and the implications for sight restoration technologies.

Authors:  Michael Beyeler; Ariel Rokem; Geoffrey M Boynton; Ione Fine
Journal:  J Neural Eng       Date:  2017-06-14       Impact factor: 5.379

2.  Valproic Acid for a Treatment of Retinitis Pigmentosa: Reasons for Optimism and Caution.

Authors:  Levi Todd; Christopher Zelinka
Journal:  J Neurosci       Date:  2017-05-24       Impact factor: 6.167

3.  Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic X. laevis Models of Retinitis Pigmentosa.

Authors:  Ruanne Y J Vent-Schmidt; Runxia H Wen; Zusheng Zong; Colette N Chiu; Beatrice M Tam; Christopher G May; Orson L Moritz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

Review 4.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

Review 5.  [Pharmacological concepts to treat hereditary retinal degenerations].

Authors:  C M Poloschek; H Jägle
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

6.  Pharmacological modulation of the retinal unfolded protein response in Bardet-Biedl syndrome reduces apoptosis and preserves light detection ability.

Authors:  Anais Mockel; Cathy Obringer; Theodorus B M Hakvoort; Mathias Seeliger; Wouter H Lamers; Corinne Stoetzel; Hélène Dollfus; Vincent Marion
Journal:  J Biol Chem       Date:  2012-08-06       Impact factor: 5.157

7.  Effect of short-term oral valproic Acid on vision and visual field in retinitis pigmentosa.

Authors:  P Mahesh Shanmugam; C K Minija; Rajesh Ramanjulu; Pradeep Tekwani; Manish Saxena
Journal:  Ophthalmol Ther       Date:  2012-11-06

8.  Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study.

Authors:  Satoshi Iraha; Yasuhiko Hirami; Sachiko Ota; Genshiro A Sunagawa; Michiko Mandai; Hidenobu Tanihara; Masayo Takahashi; Yasuo Kurimoto
Journal:  Clin Ophthalmol       Date:  2016-07-25

Review 9.  The cell stress machinery and retinal degeneration.

Authors:  Dimitra Athanasiou; Monica Aguilà; Dalila Bevilacqua; Sergey S Novoselov; David A Parfitt; Michael E Cheetham
Journal:  FEBS Lett       Date:  2013-05-15       Impact factor: 4.124

Review 10.  Gene therapy in animal models of autosomal dominant retinitis pigmentosa.

Authors:  Brian Rossmiller; Haoyu Mao; Alfred S Lewin
Journal:  Mol Vis       Date:  2012-10-06       Impact factor: 2.367
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.